These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 30745141)
1. FGF15 Activates Hippo Signaling to Suppress Bile Acid Metabolism and Liver Tumorigenesis. Ji S; Liu Q; Zhang S; Chen Q; Wang C; Zhang W; Xiao C; Li Y; Nian C; Li J; Li J; Geng J; Hong L; Xie C; He Y; Chen X; Li X; Yin ZY; You H; Lin KH; Wu Q; Yu C; Johnson RL; Wang L; Chen L; Wang F; Zhou D Dev Cell; 2019 Feb; 48(4):460-474.e9. PubMed ID: 30745141 [TBL] [Abstract][Full Text] [Related]
3. Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation. Rau M; Stieger B; Monte MJ; Schmitt J; Jahn D; Frey-Wagner I; Raselli T; Marin JJ; Müllhaupt B; Rogler G; Geier A Inflamm Bowel Dis; 2016 Oct; 22(10):2382-9. PubMed ID: 27580383 [TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Inagaki T; Choi M; Moschetta A; Peng L; Cummins CL; McDonald JG; Luo G; Jones SA; Goodwin B; Richardson JA; Gerard RD; Repa JJ; Mangelsdorf DJ; Kliewer SA Cell Metab; 2005 Oct; 2(4):217-25. PubMed ID: 16213224 [TBL] [Abstract][Full Text] [Related]
5. Hepatic Autophagy Deficiency Remodels Gut Microbiota for Adaptive Protection via FGF15-FGFR4 Signaling. Yan S; Khambu B; Chen X; Dong Z; Guo G; Yin XM Cell Mol Gastroenterol Hepatol; 2021; 11(4):973-997. PubMed ID: 33127558 [TBL] [Abstract][Full Text] [Related]
6. FXR-induced secretion of FGF15/19 inhibits CYP27 expression in cholangiocytes through p38 kinase pathway. Jung D; York JP; Wang L; Yang C; Zhang A; Francis HL; Webb P; McKeehan WL; Alpini G; Lesage GD; Moore DD; Xia X Pflugers Arch; 2014 May; 466(5):1011-9. PubMed ID: 24068255 [TBL] [Abstract][Full Text] [Related]
7. Bile acids, FGF15/19 and liver regeneration: From mechanisms to clinical applications. Alvarez-Sola G; Uriarte I; Latasa MU; Jimenez M; Barcena-Varela M; Santamaría E; Urtasun R; Rodriguez-Ortigosa C; Prieto J; Berraondo P; Fernandez-Barrena MG; Berasain C; Avila MA Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1326-1334. PubMed ID: 28709961 [TBL] [Abstract][Full Text] [Related]
8. FGF15 improves outcomes after brain dead donor liver transplantation with steatotic and non-steatotic grafts in rats. Gulfo J; Rotondo F; Ávalos de León CG; Cornide-Petronio ME; Fuster C; Gracia-Sancho J; Jiménez-Castro MB; Peralta C J Hepatol; 2020 Nov; 73(5):1131-1143. PubMed ID: 32422221 [TBL] [Abstract][Full Text] [Related]
9. Bile Acids as Hormones: The FXR-FGF15/19 Pathway. Kliewer SA; Mangelsdorf DJ Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265 [TBL] [Abstract][Full Text] [Related]
10. The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice. Li Q; Zhao Q; Zhang C; Zhang P; Hu A; Zhang L; Schroder PM; Ma Y; Guo Z; Zhu X; He X J Physiol Biochem; 2018 May; 74(2):247-260. PubMed ID: 29468415 [TBL] [Abstract][Full Text] [Related]
11. Polygonum multiflorum Thunb suppress bile acid synthesis by activating Fxr-Fgf15 signaling in the intestine. Wei J; Chen J; Fu L; Han L; Gao X; Sarhene M; Hu L; Zhang Y; Fan G J Ethnopharmacol; 2019 May; 235():472-480. PubMed ID: 30528660 [TBL] [Abstract][Full Text] [Related]
12. The Effect of Fibroblast Growth Factor 15 Signaling in Non-Steatotic and Steatotic Liver Transplantation from Cardiocirculatory Death. Avalos-de León CG; Jiménez-Castro MB; Cornide-Petronio ME; Gulfo J; Rotondo F; Gracia-Sancho J; Casillas-Ramírez A; Peralta C Cells; 2019 Dec; 8(12):. PubMed ID: 31847428 [TBL] [Abstract][Full Text] [Related]
13. Diet1 functions in the FGF15/19 enterohepatic signaling axis to modulate bile acid and lipid levels. Vergnes L; Lee JM; Chin RG; Auwerx J; Reue K Cell Metab; 2013 Jun; 17(6):916-928. PubMed ID: 23747249 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity. Wang C; Yang C; Chang JY; You P; Li Y; Jin C; Luo Y; Li X; McKeehan WL; Wang F Curr Mol Med; 2014; 14(6):703-711. PubMed ID: 25056539 [TBL] [Abstract][Full Text] [Related]
15. Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4. Gutierrez A; Ratliff EP; Andres AM; Huang X; McKeehan WL; Davis RA Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):301-6. PubMed ID: 16284190 [TBL] [Abstract][Full Text] [Related]
16. Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action. Zhang J; Gupte J; Gong Y; Weiszmann J; Zhang Y; Lee KJ; Richards WG; Li Y EBioMedicine; 2017 Feb; 15():173-183. PubMed ID: 28041926 [TBL] [Abstract][Full Text] [Related]
17. Monomeric/dimeric forms of Fgf15/FGF19 show differential activity in hepatocyte proliferation and metabolic function. Williams CM; Harper Calderon J; E H; Jimenez Y; Barringer K; Carbonaro M; Molina-Portela MDP; Thurston G; Li Z; Daly C FASEB J; 2021 Feb; 35(2):e21286. PubMed ID: 33484478 [TBL] [Abstract][Full Text] [Related]
18. Soya protein stimulates bile acid excretion by the liver and intestine through direct and indirect pathways influenced by the presence of dietary cholesterol. Arellano-Martínez GL; Granados O; Palacios-González B; Torres N; Medina-Vera I; Tovar AR Br J Nutr; 2014 Jun; 111(12):2059-66. PubMed ID: 24666631 [TBL] [Abstract][Full Text] [Related]
19. Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice. Yu Y; Shi X; Zheng Q; Wang X; Liu X; Tan M; Lv G; Zhang P; Martin RC; Li Y Int J Biol Sci; 2021; 17(10):2576-2589. PubMed ID: 34326695 [No Abstract] [Full Text] [Related]
20. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk. Bhat N; Esteghamat F; Chaube BK; Gunawardhana K; Mani M; Thames C; Jain D; Ginsberg HN; Fernandes-Hernando C; Mani A FASEB J; 2022 Mar; 36(3):e22185. PubMed ID: 35133032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]